Programmed Death Ligand-1 Testing in Triple-Negative Breast Cancer: National Practice and Interlaboratory Variation in the Netherlands
- DOI
- 10.1016/j.labinv.2026.106121
- Published
- 2026-05
- Container
- Laboratory Investigation
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.labinv.2026.106121,
title = {Programmed Death Ligand-1 Testing in Triple-Negative Breast Cancer: National Practice and Interlaboratory Variation in the Netherlands},
author = {Mirte Dekker and Maaike Anna Hempenius and Geertruida H. de Bock and Michel van Kruchten and Marcel A.T.M. van Vugt and Albert G. Siebers and Bert van der Vegt},
year = {2026},
journal = {Laboratory Investigation},
doi = {10.1016/j.labinv.2026.106121},
url = {https://doi.org/10.1016/j.labinv.2026.106121}
}RIS
TY - JOUR TI - Programmed Death Ligand-1 Testing in Triple-Negative Breast Cancer: National Practice and Interlaboratory Variation in the Netherlands AU - Mirte Dekker AU - Maaike Anna Hempenius AU - Geertruida H. de Bock AU - Michel van Kruchten AU - Marcel A.T.M. van Vugt AU - Albert G. Siebers AU - Bert van der Vegt PY - 2026 JO - Laboratory Investigation DO - 10.1016/j.labinv.2026.106121 UR - https://doi.org/10.1016/j.labinv.2026.106121 ER -
APA
Dekker, M., Hempenius, M. A., Bock, G. H. D., Kruchten, M. V., Vugt, M. A. V., Siebers, A. G., & Vegt, B. V. D. (2026). Programmed Death Ligand-1 Testing in Triple-Negative Breast Cancer: National Practice and Interlaboratory Variation in the Netherlands. Laboratory Investigation. https://doi.org/10.1016/j.labinv.2026.106121
Source records
- crossref · retrieved 2026-09-25T21:46:02.628Z